Phase II Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma Following Previous Chemotherapy

Trial Profile

Phase II Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma Following Previous Chemotherapy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 May 2017

At a glance

  • Drugs Pembrolizumab (Primary)
  • Indications Penile cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2016 Planned primary completion date changed from 1 Jul 2019 to 1 Oct 2019.
    • 28 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 22 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top